Physician profile
Alpesh Patel
NPI 1043478118
$17,809.83
in general payments reported to CMS, 2019-2025
39 companies · $1,427 in 2025
The $1,427 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,030 · 2020: $11K · 2021: $1,212 · 2022: $1,539 · 2023: $1,129 · 2024: $829 · 2025: $1,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,585 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,584.97 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $10,139.26 | 2020 | |
| Maquet Cardiopulmonary Gmbh | $800.00 | 2025 | Hls Set |
| Abbott Laboratories | $738.08 | 2019-2024 | Jot Dx, Mitraclip |
| Amgen INC. | $702.88 | 2019-2025 | Repatha, Repatha |
| Abiomed | $534.41 | 2019-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $492.45 | 2019-2023 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $490.92 | 2019-2025 | |
| Pfizer INC. | $463.05 | 2019-2025 | |
| Edwards Lifesciences Corporation | $397.33 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $342.22 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $302.62 | 2019-2024 | Watchman Flx, Watchman Access System |
| Impulse Dynamics (USA) INC. | $286.78 | 2021-2025 | Optimizer |
| Janssen Pharmaceuticals, INC | $270.08 | 2019-2024 | Xarelto |
| Alphatec Spine, INC | $264.10 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $222.59 | 2019-2025 | Farxiga |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.